Targeted radiation zaps prostate cancer in new trial
NCT ID NCT05720130
Summary
This study is testing a new radioactive drug called [²¹²Pb]Pb-ADVC001 for men with prostate cancer that has spread. The first part aims to find the safest and most effective dose. The second part will see how well that dose works to control the cancer in different groups of patients. The drug is designed to deliver radiation directly to prostate cancer cells.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PROSTATE CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Gold Coast University Hospital
RECRUITINGSouthport, Queensland, 4215, Australia
Contact
-
Princess Alexandra Hospital
RECRUITINGBrisbane, Queensland, 4102, Australia
Contact
-
Royal Brisbane & Women's Hospital
RECRUITINGBrisbane, Queensland, 4029, Australia
Contact
Conditions
Explore the condition pages connected to this study.